167 related articles for article (PubMed ID: 8586091)
1. Uptake of technetium-99m hexamethylpropylene amine oxime labelled white cells in lymph nodes involved in non-Hodgkin's lymphoma.
AL-Nahhas AM; Hjiyiannakis P; Hammersley PA; McCready VR; Horwich AH
Eur J Nucl Med; 1995 Dec; 22(12):1453-6. PubMed ID: 8586091
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of leucocytes labelled with technetium-99m hexamethylpropylene amine oxime in malignant abdominal tumours.
Lantto E; Järvi K; Lantto T; Ristkari S; Vorne M
Eur J Nucl Med; 1991; 18(10):824-8. PubMed ID: 1660402
[TBL] [Abstract][Full Text] [Related]
3. Chronic osteomyelitis: diagnosis with technetium-99m-d, l-hexamethylpropylene amine oxime labelled leucocytes.
Krznaric E; Roo MD; Verbruggen A; Stuyck J; Mortelmans L
Eur J Nucl Med; 1996 Jul; 23(7):792-7. PubMed ID: 8662118
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 99m technetium hexamethylpropylene-amine oxime labelled leucocyte with 111-indium tropolonate labelled granulocyte scanning and ultrasound in the diagnosis of intra-abdominal abscess.
Weldon MJ; Joseph AE; French A; Saverymuttu SH; Maxwell JD
Gut; 1995 Oct; 37(4):557-64. PubMed ID: 7489945
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of granulocyte CD11b (CR 3) after labelling with technetium-99m hexamethylpropylene amine oxime.
Almer S; Ljunghusen O
Eur J Nucl Med; 1995 Sep; 22(9):1039-41. PubMed ID: 7588942
[TBL] [Abstract][Full Text] [Related]
6. The use of technetium-99m hexamethylpropylene amine oxime labelled white blood cells to detect subclinical inflammation of the heart after cardiopulmonary bypass in children with congenital heart disease.
Kao CH; Hsieh KS; Wang YL; Wang SJ
Eur J Nucl Med; 1992; 19(11):960-3. PubMed ID: 1425783
[TBL] [Abstract][Full Text] [Related]
7. Measurement of the secretion of technetium-99m hexamethylpropylene amine oxime into breast milk.
Marshall DS; Newberry NR; Ryan PJ
Eur J Nucl Med; 1996 Dec; 23(12):1634-5. PubMed ID: 8929318
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of brain death with technetium 99m hexamethylpropylene amine oxime.
Costa DC; Motteux IM; McCready AC
Eur J Nucl Med; 1991; 18(7):503-6. PubMed ID: 1915475
[TBL] [Abstract][Full Text] [Related]
9. The radiation dosimetry and normal value study of 99mTc-HMPAO-labeled leukocytes.
Brown ML; Hung JC; Vetter RJ; O'Connor MK; Chowdhury S; Forstrom LA
Invest Radiol; 1994 Apr; 29(4):443-7. PubMed ID: 8034450
[TBL] [Abstract][Full Text] [Related]
10. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease.
Alonso JC; Lopez-Longo FJ; Lampreave JL; González CM; Vegazo O; Carreño L; Almoguera I
Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
Tsai CS; Kao CH; Yeh SJ; Wang SJ
Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
[TBL] [Abstract][Full Text] [Related]
12. Scintigraphic evaluation of disease activity in rheumatoid arthritis: a comparison of technetium-99m human non-specific immunoglobulins, leucocytes and albumin nanocolloids.
Liberatore M; Clemente M; Iurilli AP; Zorzin L; Marini M; Di Rocco E; Colella AC
Eur J Nucl Med; 1992; 19(10):853-7. PubMed ID: 1451700
[TBL] [Abstract][Full Text] [Related]
13. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content.
Blocklet D; Toungouz M; Kiss R; Lambermont M; Velu T; Duriau D; Goldman M; Goldman S
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):440-7. PubMed ID: 12722741
[TBL] [Abstract][Full Text] [Related]
14. Ipsilateral lymph node uptake of Tc-99m HMPAO WBC in two men with foot infections.
Vento JA; Karimeddini MK; Spencer RP
Clin Nucl Med; 1996 May; 21(5):422-3. PubMed ID: 8732852
[No Abstract] [Full Text] [Related]
15. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease.
Allan RA; Sladen GE; Bassingham S; Lazarus C; Clarke SE; Fogelman I
Eur J Nucl Med; 1993 Mar; 20(3):195-200. PubMed ID: 8462606
[TBL] [Abstract][Full Text] [Related]
16. Technetium 99m-hexamethyl propyleneamine oxime-labeled leukocytes for diagnosis of infection.
Datz FL
West J Med; 1992 Jul; 157(1):60-1. PubMed ID: 1413746
[No Abstract] [Full Text] [Related]
17. Technetium-99m-HMPAO cerebral perfusion scintigraphy: considerations for timely brain death declaration.
Larar GN; Nagel JS
J Nucl Med; 1992 Dec; 33(12):2209-11. PubMed ID: 1460517
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m hexamethylpropylene amine oxime labelled leucocyte scintigraphy in ulcerative colitis and Crohn's disease.
Papós M; Nagy F; Láng J; Csernay L
Eur J Nucl Med; 1993 Sep; 20(9):766-9. PubMed ID: 8223770
[TBL] [Abstract][Full Text] [Related]
19. Fast diagnosis of abdominal infections with technetium-99m-HMPAO-leukocytes.
Karalasingam L
J Nucl Med; 1992 Jun; 33(6):1253. PubMed ID: 1597749
[No Abstract] [Full Text] [Related]
20. The utility of [99mTc]HMPAO-leukocytes for imaging infection.
Peters AM
Semin Nucl Med; 1994 Apr; 24(2):110-27. PubMed ID: 8023168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
